BofA: Bristol update may boost Cytokinetics shares
Go back to BofA: Bristol update may boost Cytokinetics shares| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 61.15 +0.32 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.83 | 52 Week High | $77.12 | |||
| Open | $60.66 | 52 Week Low | $49.03 | |||
| Day High | $61.24 | P/E | 39.71 | |||
| Day Low | $60.24 | EPS | $1.54 | |||
| Volume | 9,935,527 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 65.60 -0.02 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.62 | 52 Week High | $13.18 | |||
| Open | $66.45 | 52 Week Low | $6.00 | |||
| Day High | $66.91 | P/E | N/A | |||
| Day Low | $64.49 | EPS | $-1.24 | |||
| Volume | 2,655,075 | |||||
